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Abstract: Carcinogenic/toxic effects of ochratoxin A (OTA) in various internal organs of 
Plymouth Rock chicks were determined. The number of OTA-induced neoplasms was 
similar in chicks given 25 ppm L--phenylalanine (PHE) in addition to 5 ppm OTA 
compared to chicks given only 5 ppm OTA, which showed that PHE cannot be used as a 
real protector against the carcinogenic or toxic effects of OTA in chicks. OTA was found 
to provoke strong degenerative changes in liver and kidneys, degenerative changes and 
depletion of cells in lymphoid organs, oedematous and degenerative changes in the brain, 
muscular haemorrhages and fatty changes in the bone marrow. The target organs for 
carcinogenic effect of OTA in chicks were found to be kidneys and liver. 
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1. Introduction 
Ochratoxin A (OTA) is a mycotoxin widely encountered in animal feeds and human foods. The 
most obvious effects of OTA-contaminated feed on chicks are reported to be reduced rates of weight 
gain [1–3], decreased egg production [4], immunosuppressive effects [2] and increased mortality [5]. 
In addition, there are many other reports on various carcinogenic effects of OTA, but in these attention 
is usually focussed on mice or rats [6–8] and there is a lack of evidence with regard to carcinogenic 
effects of OTA on chicks. It is also known that the IARC has classified OTA as a possible human 
carcinogen (group 2B) based on sufficient evidence for OTA-carcinogenicity obtained from various 
animal experiments [9]. 
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Feed supplements are often studied with regard to their potential to ensure safely utilisation of some 
mycotoxin-contaminated feeds. Haazele et al. [4] reported that ascorbic acid supplementation in laying 
hen diets can partially reduce the toxic effects of nephrotoxic mycotoxin OTA. Some authors suggest 
that part of the toxic effect of OTA is due to the structural homology with phenylalanine (PHE), 
resulting in an inhibition of protein synthesis due to a competition for the specific t-RNA [10,11]. 
However, this effect has been demonstrated only in bacteria and yeast [10,11], but has never been seen 
in animals. Nevertheless, a protective effect of PHE administration has been reported by some   
authors [12]. Therefore, PHE was used in the present experiment in other to evaluate its possible 
protective effect against OTA.  
This experiment could be considered as an extension of our former short term studies on the toxic 
effects of OTA on various internal organs, biochemical indices and body weight gain in stock chicks, 
published in Toxicology Letters [3]. The main aim of the present study was to evaluate the possible 
long term toxic or carcinogenic effects of OTA and the possible protective effects of PHE.  
2. Materials and Methods 
2.1. OTA production 
A strain of Aspergillus ochraceus (isolate D2306, as used by Tapia and Seawright [13], and   
Stoev et al. [3]) was grown on sterilised shredded wheat (40 g) in 500 mL conical flasks moistened by 
a 40% (v/w) addition of sterile water and incubated on a rotary shaker at 27 C for 2 weeks [14]. The 
brown granular product was then sterilised at 80 C for 1 hour and stored at −20 C until the study. A 
sample was analysed by HPLC with diode array detection for OTA and found to contain ~2 mg/g of 
this compound and a relatively small amount of its dechloro-analogue ochratoxin B [14]. No other 
mycotoxins were produced in this solid substrate fermentation process and the necessary dilution by 
approximately 10
3 when homogenised into chick ration made only a minimal addition of other 
components of the moulded shredded wheat substrate. 
2.2. Experimental design 
Specific pathogen-free chicks (Plymouth Rock) were purchased at two-weeks of age, housed in 
wire floor cages (two chicks in each cage with more than 500 cm
2 per chick at the beginning of 
experiment; one chick in each cage with more than 1,000 cm
2 per chick at later stages of sexual 
maturity) with continuous infra-red lighting at a temperature suitable for their age. Commercially 
prepared complete standard feed (Smesler, Stara Zagora, Bulgaria) suitable for the breed and age of 
the chicks according to the accepted standards and regulations of the country, which contained the 
defined concentrations of OTA with or without PHE supplementation, supposed to protect against the 
toxic effects of OTA, were available ad libitum during the whole experimental period as described in 
Table 1. The chicks were grouped in two experimental and one control group (10 chicks in each 
group—five males and five females) as shown in Table 1. 
The L- PHE (Finomvegyszergyar, Budapest, Hungary) was used in 5:1 molar ratio with regard to 
OTA as the higher doses (above 10:1 molar ratio) provide only a slight protection against OTA, 
because of increasing the absorption of OTA from the stomach and intestine. In addition, the higher Toxins 2010, 2                                       
 
 
651
supplementation of pure phenylalanine in diets contaminated with OTA also tended to create an amino 
acid imbalance, which reduced b. w. gain and feed conversion efficiencies [15,16]. 
Table 1. Amount of ochratoxin A (OTA) and PHE in experimental feeds of chicks. 
Group  Added OTA in feed (ppm - mg/kg)  Added PHE in feed 
Control none  none 
1 5  none 
2 5 
0.0025% (0.025 g/kg feed - 25 ppm) 
L- PHE 
OTA—ochratoxin A; PHE—phenylalanine. 
 
The Trakia University Animal Care Ethic Committee approved the study protocol and chicks were 
housed, maintained and slaughtered in accordance with the Bulgarian Welfare Regulations. 
2.3. Measurements of tumours incidents  
All chicks were examined for the existence of various neoplastic tissues at the end of the two years 
experimental period, when the same were slaughtered. Such examination was also made in all chicks, 
which were dead during the experiment. Non-parametric Mann–Whitney and Student’s t-test were 
used to estimate significant differences between tumour incidences in experimental and control groups.  
2.4. Histological examination  
Materials for histological examination were taken at slaughter time (at about 24-months age) or 
after the death of the chicks from kidneys, liver, heart, thymus, bursa Fabricii, spleen, intestine, 
cerebellum, brain, medulla and bone marrow as well as from various neoplastic tissues. The same were 
fixed in 10% neutral buffered formalin or processed for freezing microtome. The freezing materials 
were stained with Sudan III for proving the fat. The fixed tissues were processed for paraffin 
embedding, sectioned at 6 µm and stained with haematoxylin-eosin. Periodic acid-Schiff (PAS) stain 
was also used for proving of lipoproteid, glycoproteid or mucoproteid substances in various tissues and 
cell components, and especially for proving the thickening of basement tubular membranes (with 
lipoprotein structure). Some materials were stained according to Weigert iron haematoxylin for 
proving the presence or absence of fibrin in various cyst formations. 
3. Results  
3.1. Clinical observation and gross pathology 
The most obvious clinical signs as weakness or dullness, goose plumage, transient diarrhoea and 
growth depression were seen in all chicks from the groups treated with OTA, but the same were less 
pronounced in chicks supplemented additionally with PHE. Various nervous symptoms such as 
torticollis, emprosthotonus, lurch, reeling gait (staggering step) and tremor were seen in different 
degree in all chicks treated with OTA alone, but only in half of the chicks treated with PHE in addition 
to OTA. Some of these clinical signs as weakness or dullness were seen just after 2–3 weeks of Toxins 2010, 2                                       
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feeding the contaminated diet, whereas other signs as nervous symptoms appeared after 10–15 weeks, 
but were more pronounced at the end of the first year of the experiment. 
At the end of the 10th month of the experiment one male chick from group 1 was dead. Several 
large grey-white neoplastic spots were seen in the diaphragmatic and abdominal surfaces of the liver in 
the same chick (Figure 1), which were subsequently diagnosed as adenocarcinoma. The same 
protruded significantly above the liver surface (Table 2). 
Figure 1. Adenocarcinoma in the liver of male chick of group 1 exposed to 5 ppm OTA 
via the feed, which died at the end of the 10th month of the experiment. Large grey-white 
neoplastic foci are seen in the liver and protruded significantly above its surface. 
 
Table 2. Kind of neoplasm and time of establishment in various tissue or organs of male or 
female chicks exposed to OTA and treated with or without PHE via the ingested feeds.  
Group 
OTA in feed 
(ppm-mg/kg) 
PHE in 
feed 
Kind of 
neoplasm  
Benign or 
malignant 
Time of 
establishment 
Tissues or 
organs 
Sex of 
chick 
1 5  none  adenocarcinoma  malignant  10
th month  liver  male 
1 5  none  lymphosarcoma  malignant  18
th month  kidney  male 
1 5  none  carcinoma  malignant  20
th month  ureters  male 
1 5  none  cystic  adenoma  benign  24
th month  kidneys  male 
1 5  none  cystic  adenoma  benign  24
th month  kidneys  female 
2 5  L-b  PHE  adenocarcinoma  malignant  19
th month  kidney  female 
2 5  L-b  PHE  carcinoma  malignant  21
st month  liver, spleen  female 
2 5  L-b  PHE  rabdomyoma  benign  24
th month  breast muscle  female 
OTA—ochratoxin A, PHE—phenylalanine. 
 
Four chicks died between the 12th and 24th month from the beginning of the experiment, because 
of development of different kind of malignant tumours diagnosed as lymphosarcoma in kidney (chick 
from group 1), adenocarcinoma in kidney (chick from group 2), carcinoma in the region of ureters 
(chick of group 1—Figure 2), carcinoma in the liver and spleen (chick of group 2—Figure 3) at the 
time of pathomorphological examination (Table 2). Toxins 2010, 2                                       
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Figure 2. Carcinoma in the region of ureters of male chick of group 1 exposed to 5 ppm OTA 
via the feed, which died at the end of the 20th month of the experiment. Large grey-white 
neoplastic foci are seen along the ureters and protruded significantly above its surface. 
 
 
Figure 3. Carcinoma in the liver and spleen of female chick of group 2 exposed to 5 ppm 
OTA and 25 ppm PHE via the feed, which died at the end of the 21st month of the 
experiment. Small grey-white neoplastic foci are seen on the surface of liver and spleen. 
 
 
Two more benign tumours were found at the slaughter time (24 months from the beginning of 
experiment). The same were defined microscopically as rhabdomyoma in the breast muscles (chick 
from group 2—Figure 4) or adenomas in the kidney (Table 2). There were no any neoplasms in the 
chicks from control group. 
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Figure 4. Rabdomyoma in the breast muscle of female chick of group 2 exposed to 5 ppm 
OTA and 25 ppm PHE via the feed, which was slaughtered at the end of the 24th month of 
the experiment. Large neoplasia in the region of breast muscle, which protruded 
significantly above the surface. 
 
 
The comparison between experimental and control groups revealed a significant increase of tumour 
incidents in the chicks exposed to OTA towards the controls, but no significant protective effect was 
found in regard to PHE. 
Gross pathology examination at the end of the two-year experimental period revealed that all chicks 
from OTA-treated group were emaciated and their bones were sometimes thin or soft. There were 
some musclular haemorrhages and slight catarrhal enteritis in the same chicks. In addition, slight 
subcutaneous oedema was found in a few chicks from the same group. Kidneys and liver in the same 
experimental chicks as well as in the chicks supplemented with PHE in addition to OTA were slightly 
paler than in the chick of control group, whereas their gall bladders were enlarged and full of bile. A 
different extent of contraction and diminished size of kidneys were also observed in OTA-treated 
chicks and in lesser extent in chicks additionally supplemented with PHE. Some parts of the bone 
marrow in OTA-treated chicks were with grey-white colour, whereas others showed a preservation of 
the normal red colour. The meninges of the same chicks were slightly hyperaemic. There were no 
gross pathology changes in the chicks from control group. 
3.2. Histopathology 
Pathomorphological investigation of kidneys showed degenerative changes (granular or hydropic 
degeneration, karyomegaly, karyopyknosis or karyorrhexis) in epithelial cells of the proximal 
convoluted tubules, cystiform dilatation of the lumen of some tubules, tubular atrophy in other tubules, 
mononuclear proliferation in the mucosa of ureters, and moderate proliferation of connective tissue 
and mononuclear cells in the renal interstitium, seen mainly in chicks of OTA-treated group and in 
lesser extent in chicks of group additionally treated with PHE. Different degree of congestion of 
peritubular capillaries, oedema, activation and proliferation of capillary- or vascular endothelium and 
vascular adventitial cells of kidneys were also seen in the same both groups. The existence of various Toxins 2010, 2                                       
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kinds of distended tubules with atypical epithelial cells was also a frequent finding in the kidneys of 
the same chicks. 
In the case of the initial solid carcinoma in the region of ureters (Figure 2), many secondary 
metastases were also found in the kidneys (Figure 5). These metastatic spots showed infiltrative or 
destructive growth within adjacent parenchyma and pronounced polymorphism of neoplastic cells, 
which had large hypochromatic or polychromatic nuclei, and many irregular mitoses. Large necroses 
were also found among the neoplastic tissue (Figure 6). In a few places these solid carcinomatous 
formations changed into small cyst-like formations lined with several layers neoplastic cells 
(adenocarcinoma). 
Figure 5. Photomicrograph of the secondary metastases in the kidneys coming from the 
initial carcinoma in the region of ureters of male chick of group 1 exposed to 5 ppm OTA 
via the feed, which died at the end of the 20th month of the experiment. Infiltrative or 
destructive growth and pronounced polymorphism of neoplastic cells, showing large 
hypochromatic or polychromatic nuclei. Carcinomatous and single cyst-like formations in 
the kidneys. HE × 400. 
 
Figure 6. Photomicrograph of the carcinoma in the region of ureters of male chick of 
group 1 exposed to 5 ppm OTA via the feed, which died at the end of the 20th month of the 
experiment. Large necroses among the neoplastic tissue. HE  100. 
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The adenocarcinoma of kidneys showed cyst-like formations lined with several layers of atypical 
cells with polymorphism and large hypochromatic or polychromatic nuclei. Several metastases in the 
lung were also found in the same chick. 
The lymphosarcoma of kidneys was accompanied by glomerular or tubular atrophy and large 
necroses among the neoplastic tissue. 
The cystic adenomas of kidney had small sizes without destructive growth and penetration in the 
adjacent parenchyma and were constituted of cyst-like formations lined with one layer neoplastic cells 
without polymorphism or metastases in the adjacent parenchyma. 
In the liver, cloudy swelling, granular degeneration and rarely fatty changes of the hepatic cells 
were seen in the chicks of OTA-treated group, but the same changes were less obvious in the chicks 
supplemented with PHE. Activation of capillary endothelium and Kupffer's cells, hyperaemia, 
pericapillary oedema, perivascular mononuclear cell infiltration, proliferation of connective tissue and 
bile ducts were also noticed, mainly in the chicks of OTA-treated group. 
In the case of adenocarcinoma in the liver, neoplastic tissue showed infiltrative or destructive 
growth within adjacent parenchyma and was constituted of cyst-like formations lined with several 
layers of neoplastic cells (Figure 7) having polymorphism and large hypochromatic or polychromatic 
nuclei along with small quantity of cytoplasm and lots of irregular mitoses. In some places these  
cyst-like formations were replaced by solid carcinomatous formations having an increased 
polymorphism, large quantity of irregular mitoses, and lots of polychromatic nuclei. A small quantity 
of secret with desquamated epithelial cells was seen in the lumen of some cyst-like formations. Large 
necroses were often seen among the neoplastic tissue. Strong degenerative changes, in addition to 
slight polymorphism of hepatic cell, including polychromatic nuclei, were found in the parenchyma 
adjacent to neoplastic tissue. Intranuclear inclusions were sometimes seen in some of the neoplastic 
cells or in the hepatic cells adjacent to neoplastic tissue. Different degree of karyomegaly was also 
observed in some hepatic cells adjacent to neoplastic areas. Slight to moderate hyperaemia of 
capillaries or vessels was seen in the same areas.  
Figure 7. Photomicrograph of the adenocarcinoma in the liver of male chick of group 1 
exposed to 5 ppm OTA via the feed, which died at the end of the 10th month of the 
experiment. Neoplastic cells having large hypochromatic or polychromatic nuclei and 
giving cyst-like formations lined with several layers of neoplastic cells. HE  300. 
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The carcinoma of liver and spleen showed lots of similar neoplastic spots in both liver and spleen. 
Neoplastic carcinoma cells had an increased polymorphism, large quantity of irregular mitoses, lots of 
polychromatic nuclei and small necroses among neoplastic tissue (Figure 8). Carcinoma cells showed 
a typical strong infiltrative or destructive growth within adjacent parenchyma. 
Figure 8. Photomicrograph of the carcinoma in the liver of female chick of group 2 
exposed to 5 ppm OTA and 25 ppm PHE via the feed, which died at the end of the 21st 
month of the experiment. Small carcinomatous formations of neoplastic cells having an 
increased polymorphism, large quantity of irregular mitoses, lots of polychromatic nuclei 
and destructive growth within the adjacent parenchyma. HE  300. 
 
 
In the thymus and bursa of Fabricius, a depletion of lymphoid cells, atrophy, necroses or cyst 
formations in the lymph tissue were seen in the chicks of both OTA-treated groups. In the chicks of 
control group, only atrophy of lymph tissue or lymph follicles as well as proliferation of connective 
tissue around the follicles, corresponding to the involution of the same organs, were seen. A cellular 
depletion or degenerative changes were also found in the white pulp and germinal centres of the spleen 
in the chicks of the both OTA-treated groups.  
Slight to moderate degenerative changes or depletion of lymphoid cells were also seen in the lymph 
follicles of intestinal mucosa in the chicks of both OTA-treated groups. A mononuclear and 
heterophilic cell infiltration was often seen in the lamina propria of intestinal mucosa of the same 
chicks. Small foci of focal necrosis and loss of surface epithelium accompanied by degenerative 
changes in the glandular epithelium were found only in the intestinal mucosa of chicks treated with 
OTA alone. 
In the heart, granular or vacuolar degeneration, lytic changes or irregular staining as a result of the 
increased eosinophilia of some myofibrils as well as activation of capillary endothelium and 
perivascular oedema were mainly seen in the chicks treated only with OTA, while the same changes 
were less pronounced in the chicks additionally supplemented with PHE. 
In the case of rabdomyoma in the breast muscle, the neoplastic tissue was constituted of   
myofibrile-like but not striated muscle cells showing a much paler colour compared to the ordinary 
myofibrils. Destructive growth or metastases in the adjacent areas were not observed. Toxins 2010, 2                                       
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In the lung, only perivascular or peribronchial mononuclear cell infiltration was found in some 
chicks of both groups treated with OTA.  
The pericapillary or pericellular oedema and lytic changes in neurons and glia cells were the most 
obvious pathological changes in the brain of all OTA-treated chicks. Activation and proliferation of 
capillary- or vascular endothelium and vascular adventitial cells were seen in some vessels of the brain 
in the chicks of the group treated with OTA alone. Small foci of proliferation of glia cells around some 
vessels or necrotic neurons were rarely seen in OTA-treated chicks. 
Similar oedematous and degenerative changes were also found in the cerebellum, mainly in the 
region of the Purkinje's cells, in the chicks of both OTA-treated groups. Well visible oedematous 
changes in the white substance of cerebellum were also found in the chicks treated with OTA alone. 
In the medulla, lysis and pyknosis of tigroid substance of some neurons were seen mainly in the 
lumbosacral region in the chicks of the group treated with OTA alone. 
In the bone marrow, cell depletion and fatty changes were only noticed in the chicks of both 
experimental groups. 
No pathological changes or neoplasms were seen in the internal organs of the control chicks. Only a 
natural involution of the bursa of Fabricius and thymus were found in the same chicks. 
4. Discussion 
The neoplasms (tumours) and pathological changes observed in experimental chicks are considered 
to be due to OTA-exposure, because such pathological changes or tumours were not observed in the 
control chicks and no infections or other diseases were seen in any of the experimental chicks. 
Histopathological changes seen in both experimental groups of chicks correspond well to the 
clinical signs observed. The strong degenerative changes seen in the epithelial cells of the kidneys or 
the liver could be explained by the route of elimination of OTA via the kidneys and the liver, having in 
mind, enterohepatic recirculation and hepatobiliar way of excretion of OTA [17]. In such a way this 
mycotoxin can exert a direct toxic or carcinogenic effect on these organs [1,2]. That could explain the 
main localization of various neoplasms in the both organs. The most obvious lesions in the kidneys 
were present in the epithelium of proximal tubules in chicks of all experimental groups, whereas the 
proliferative changes in the interstitium could be considered as a sequence of the strong degenerative 
changes in the epithelium and vessels in later stages of OTA exposure. Oedematous changes in the 
brain and cerebellum in addition to various subcutaneous haemorrhages might be due to the vascular 
damages induced by OTA [2,3,18,19], which are considered to be typical for later stages of this 
nephropathy. A disturbance of blood clotting due to a reduction in the concentration of fibrinogen in 
the blood and an increase in the prothrombin time, found in OTA-treated animals [20,21], could also 
contribute to the haemorrhages observed. 
The observed karyomegaly in hepatic cells adjacent to neoplastic tissue should be considered as an 
indicator of the partial regenerative activity of parenchyma in the damaged area [22]. On the other 
hand, karyomegaly and especially aneuploidy or polyploidy in the nuclei, in addition to cellular 
polymorphism, usually are considered as pre-carcinogenic state and good indicators for future 
carcinogenic transformations of the cells, when the same are further exposed to target carcinogens. 
Similar pathological changes were recently observed in rats fed OTA [23,24].  Toxins 2010, 2                                       
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On the other hand, various kinds of distended tubules with atypical epithelial cells in the kidneys 
could be considered as pre-neoplastic kidney lesions in the affected kidneys [25], whereas benign 
adenomas in kidneys are usually the initial stage of development of malignant tumours in kidneys [26]. 
Several line of evidences indicated that carcinogenic effect of OTA is correlated to its genotoxic effect 
reflected by DNA-adducts formation [8,27,28]. It is also important to mention, that the genotoxic effect 
in various animals has been observed in significantly low OTA-intake, similar to that observed in 
humans. The more frequent neoplasms in the male chicks in comparison to the female is well 
corresponding to the studies of Bendele et al. [29], Castegnaro et al. [7] and Pfohl-Leszkowicz et al. 
[30,31], who found a similar trend among the male mice or rats exposed to diet containing OTA. 
According to Pfohl-Leszkowicz et al. [30,32] this sex-specific response could be due to the difference 
in some drag-metabolizing enzymes that convert OTA into reactive intermediates. However, in chicks 
given PHE, such a higher sensitivity in male chicks to carcinogenic effect of OTA was not observed in 
the present study. 
The circumstance, that some of the tumours were situated in the liver, in contrast to other farm 
animals, correspond well to the fact that a large amount of OTA in chicks is also excreted via the liver 
and not only via the kidneys, which may explain the strong degenerative changes found in livers of 
OTA-treated chicks. A similar finding of OTA-induced tumours, including liver neoplasms, is also 
characteristic for mice or rats [6,26]. Unfortunately, there is not information available about similar 
kind of experiments among chicks and further comparison would not be able to be done.  
The found carcinoma in the ureters of chick is really interesting findings, which is in good 
agreement with the high frequency of carcinoma in the renal pelvis, ureters and urinary bladder found 
in patients suffering from Balkan Endemic Nephropathy [33,34], a disease supposed to be caused by 
nephrotoxic mycotoxins and mainly OTA. Such carcinomas have not been seen in any kind of farm 
animals so far. In this regard, it is important to mention that some tumours in kidneys and bladders 
from patients living in areas associated with Balkan Endemic Nephropathy have been found to contain 
DNA adducts similar to those obtained from the kidneys of mice exposed to OTA [35–37], which 
suggests about the possible role of OTA in the development of these tumours of the urinary tract. 
It has been found that OTA decreases natural killer cell activity by the specific inhibition of 
endogenous interferon levels [38]. As natural killer cells are involved in the destruction of tumour 
cells, the ability of OTA to modulate the activity of these cells might contribute to its capacity to 
induce renal and hepatic carcinomas [38]. 
In field conditions OTA is only part of a complex array of mould metabolites, such as penicillic 
acid, fumonisins, citrinin, etc. [39,40], which have also carcinogenic effects [41–44] and may interact 
in this dimension with OTA, which is also proven carcinogen. Moreover, fumonisin B1 was found to 
have a pronounced nephrotoxic effect on animal kidneys [45–48], which can be additive to 
nephrotoxic effect of OTA [37,39,40]. All these circumstances suggest the importance of the relatively 
lower doses of OTA that commercial chicks may encounter in some feeds. 
The utilization of various means to reduce OTA-toxicity (as PHE supplementation) supposes a good 
understanding of the possible mechanisms of OTA-toxicity: an inhibition of enzymes involved in 
phenylalanine metabolism (including phenylalanyl transferase and phenylalanine hydroxylase), an 
effect on lipid peroxidation, an effect on mitochondrial function (inhibition of ATP production), an 
ability to provoke a dose-related increase in sister chromatid exchange (SCE) in Chinese hamster Toxins 2010, 2                                       
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ovary cells (CHO) and to cause DNA single-strand break [25,26,49,50]. This approach includes an 
addition of PHE and protein to the diet, because PHE moiety of OTA could competitively inhibits at 
least two enzymes as has been reported in bacteria or yeast: phenylalanyl-tRNA synthetase and 
phenylalanine hydroxylase, resulting in reduced protein synthesis and altered rates of tyrosine 
production from PHE. In such a way, co-administration of PHE with OTA may reduce OTA-induced 
inhibition of protein synthesis [51,52]. In this regard, a slight protective effect of PHE was previously 
found against OTA-provoked immunosuppression in humoral immune response that was supposed to 
be due to improvement of protein synthesis, which is usually disturbed by OTA and subsequently, 
improvement of OTA-induced delay of the division of the cells of the immune system [3].  
It was surprising however, that the protective effect of PHE in the present experiment was 
significantly lower than our expectation. This could be explained by the circumstance that PHE was 
found to increase the absorption of OTA from the stomach and intestine as well as the gastrointestinal 
transit of OTA resulting in fourfold up to eightfold higher levels of OTA in serum, as has been 
reported in some experiments with mice [17]. On the other hand the main mechanisms of   
OTA-toxicity in our case may not involve the inhibition of phenylalanine metabolizing enzymes. It has 
been demonstrated recently that carcinogenic and nephrotoxic processes induced by OTA are driven 
by two independent pathways: one involving a mainly oxidative pathway and another involving the 
biotranformation into gentoxic OTA derivatives [31]. 
5. Conclusions 
In this study we demonstrated that OTA induces significant pathomorphological damages in 
kidneys, liver, lymphoid organs, brain and bone marrow of chicks, as well as some tumours in kidneys, 
ureters, liver, spleen and muscles. A significant protection of PHE against the carcinogenic or toxic 
effects of OTA in chicks was not observed in the present experiment.  
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